MAGNE B6

This brand name is authorized in Estonia, France, Lithuania, Romania

Active ingredients

The drug MAGNE B6 contains a combination of these active pharmaceutical ingredients (APIs):

1 Magnesium lactate UNII IRT310VU4Z - MAGNESIUM LACTATE DIHYDRATE

Read about Magnesium lactate

2 Pyridoxine UNII 68Y4CF58BV - PYRIDOXINE HYDROCHLORIDE

Pyridoxine hydrochloride is Vitamin B6. It is converted to pyridoxal phosphate which is the co-enzyme for a variety of metabolic transformations. It is essential for human nutrition. Read about Pyridoxine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A12CC30	Magnesium (different salts in combination)	A Alimentary tract and metabolism → A12 Mineral supplements → A12C Other mineral supplements → A12CC Magnesium
Discover more medicines within A12CC30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1115211, 1816512
Country: FR	Base de données publique des médicaments	Identifier(s): 68617360
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1015401, 1016613, 1059250, 1064032, 1066398, 1089897
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68125001, W68126001, W68126002, W68127001, W68127002, W68127003